IDEXX Laboratories (IDXX)
(Delayed Data from NSDQ)
$499.30 USD
+10.06 (2.06%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $499.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
IDXX 499.30 +10.06(2.06%)
Will IDXX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for IDXX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IDXX
Philips (PHG) Receives FDA Warning Letter Regarding CT Systems
Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
IDXX: What are Zacks experts saying now?
Zacks Private Portfolio Services
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
Other News for IDXX
The spread of avian flu to cattle could have implications for some stocks
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today
Baron Focused Growth Fund Q1 2024 Shareholder Letter
Eaton Vance Worldwide Health Sciences Fund Bolsters Position in IDEXX Laboratories
Top 10 most oversold S&P 500 stocks